Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sam Schulman

Showing results (21-30 of 308) with videos related to

Pageof 31
Sort By:
Hamostaseologie|June 4, 2008
Extension of anticoagulation after venous thromboembolism - risk factors influencing the decisionSam Schulman
Thrombosis and Haemostasis|October 12, 2012
Is the network meta-analysis (NETMA) bringing us closer to the truth? Insights from recent antithrombotic drug dataSam Schulman
The Annals of Pharmacotherapy|January 31, 2002
Inhibition of warfarin activity by ribavirinSam Schulman
Pathophysiology of Haemostasis and Thrombosis|July 21, 2006
Thromboprophylaxis in medical patients--why not for all?Sam Schulman
Thrombosis Research|March 5, 2013
New anticoagulants in atrial fibrillation managementSam Schulman
The New England Journal of Medicine|June 14, 2013
Extended anticoagulation in venous thromboembolismSam Schulman, ,
Blood|March 19, 2016
Less menorrhagia for women with VTESam Schulman
Seminars in Thrombosis and Hemostasis|June 2, 2018
Recent Advances in Thrombosis and Hemostasis - Part IIISam Schulman
Blood|January 4, 2024
CHC and surgery: when is stopping safe?Sam Schulman
Lakartidningen|July 5, 2003
[There is evidence for prolonged low-intensity warfarin therapy after venous thrombosis]Sam Schulman
Pageof 31

Showing results (21-30 of 308) with videos related to

Sort By:
Pageof 31
Hamostaseologie|June 4, 2008
Extension of anticoagulation after venous thromboembolism - risk factors influencing the decisionSam Schulman
Thrombosis and Haemostasis|October 12, 2012
Is the network meta-analysis (NETMA) bringing us closer to the truth? Insights from recent antithrombotic drug dataSam Schulman
The Annals of Pharmacotherapy|January 31, 2002
Inhibition of warfarin activity by ribavirinSam Schulman
Pathophysiology of Haemostasis and Thrombosis|July 21, 2006
Thromboprophylaxis in medical patients--why not for all?Sam Schulman
Thrombosis Research|March 5, 2013
New anticoagulants in atrial fibrillation managementSam Schulman
The New England Journal of Medicine|June 14, 2013
Extended anticoagulation in venous thromboembolismSam Schulman, ,
Blood|March 19, 2016
Less menorrhagia for women with VTESam Schulman
Seminars in Thrombosis and Hemostasis|June 2, 2018
Recent Advances in Thrombosis and Hemostasis - Part IIISam Schulman
Blood|January 4, 2024
CHC and surgery: when is stopping safe?Sam Schulman
Lakartidningen|July 5, 2003
[There is evidence for prolonged low-intensity warfarin therapy after venous thrombosis]Sam Schulman
Pageof 31